Primary |
Depression |
39.5% |
Product Used For Unknown Indication |
24.9% |
Drug Use For Unknown Indication |
7.2% |
Insomnia |
6.2% |
Anxiety |
3.7% |
Major Depression |
3.5% |
Sleep Disorder |
3.0% |
Bipolar Disorder |
1.2% |
Bipolar I Disorder |
1.2% |
Pain |
1.2% |
Hypertension |
1.1% |
Gastrostomy |
1.1% |
Depressive Symptom |
0.8% |
Panic Disorder |
0.8% |
Crohn's Disease |
0.8% |
Diabetes Mellitus |
0.8% |
Panic Attack |
0.8% |
Schizophrenia |
0.8% |
Antidepressant Therapy |
0.7% |
Depressed Mood |
0.7% |
|
Suicide Attempt |
14.7% |
Completed Suicide |
11.9% |
Overdose |
6.4% |
Somnolence |
6.4% |
Weight Increased |
6.4% |
Serotonin Syndrome |
5.8% |
Vomiting |
5.8% |
Tachycardia |
4.8% |
Weight Decreased |
4.2% |
Suicidal Ideation |
3.8% |
Condition Aggravated |
3.2% |
Oedema |
3.2% |
Off Label Use |
3.2% |
Tremor |
3.2% |
Drug Ineffective |
2.9% |
Epilepsy |
2.9% |
Loss Of Consciousness |
2.9% |
Rhabdomyolysis |
2.9% |
Toxicity To Various Agents |
2.9% |
Convulsion |
2.6% |
|
Secondary |
Depression |
30.9% |
Drug Use For Unknown Indication |
23.7% |
Product Used For Unknown Indication |
10.8% |
Anxiety |
8.6% |
Insomnia |
5.0% |
Pain |
3.2% |
Bipolar Disorder |
2.4% |
Sleep Disorder |
2.4% |
Hypertension |
2.1% |
Diabetes Mellitus |
1.3% |
Cardiac Disorder |
1.2% |
Crohn's Disease |
1.2% |
Chest Pain |
1.0% |
Convulsion |
1.0% |
Schizoaffective Disorder |
1.0% |
Ill-defined Disorder |
0.9% |
Bipolar I Disorder |
0.9% |
Hepatitis C |
0.9% |
Migraine |
0.8% |
Blood Cholesterol Increased |
0.8% |
|
Suicide Attempt |
10.9% |
Weight Decreased |
8.0% |
Weight Increased |
7.7% |
Somnolence |
7.4% |
Tachycardia |
7.4% |
Vomiting |
6.2% |
Overdose |
5.3% |
Completed Suicide |
5.0% |
Drug Ineffective |
4.4% |
Serotonin Syndrome |
4.4% |
Tremor |
4.4% |
Pulmonary Embolism |
4.1% |
Altered State Of Consciousness |
3.5% |
Pyrexia |
3.5% |
Thrombosis |
3.5% |
Suicidal Ideation |
3.2% |
Urinary Tract Infection |
3.2% |
Emphysema |
2.7% |
Toxicity To Various Agents |
2.7% |
Drug Hypersensitivity |
2.4% |
|
Concomitant |
Depression |
19.8% |
Product Used For Unknown Indication |
16.1% |
Drug Use For Unknown Indication |
12.1% |
Anxiety |
8.8% |
Pain |
6.7% |
Insomnia |
5.0% |
Sleep Disorder |
4.6% |
Bipolar Disorder |
4.3% |
Hypertension |
3.9% |
Multiple Myeloma |
2.0% |
Gastrooesophageal Reflux Disease |
1.9% |
Schizophrenia |
1.9% |
Crohn's Disease |
1.8% |
Multiple Sclerosis |
1.7% |
Diabetes Mellitus |
1.7% |
Nausea |
1.6% |
Constipation |
1.5% |
Osteoporosis |
1.5% |
Rheumatoid Arthritis |
1.5% |
Asthma |
1.5% |
|
Type 2 Diabetes Mellitus |
17.7% |
Weight Increased |
12.2% |
Weight Decreased |
10.9% |
Vomiting |
8.0% |
Urinary Tract Infection |
4.3% |
Vision Blurred |
4.3% |
Nausea |
4.0% |
Death |
3.9% |
Tremor |
3.9% |
Suicide Attempt |
3.5% |
Suicidal Ideation |
3.4% |
Drug Ineffective |
3.4% |
Pneumonia |
3.0% |
Somnolence |
3.0% |
Pancreatitis |
2.9% |
Pulmonary Embolism |
2.9% |
Myocardial Infarction |
2.2% |
Wheezing |
2.2% |
White Blood Cell Count Increased |
2.2% |
Off Label Use |
2.0% |
|
Interacting |
Depression |
26.8% |
Dementia With Lewy Bodies |
7.4% |
Drug Use For Unknown Indication |
7.0% |
Hiv Infection |
6.6% |
Product Used For Unknown Indication |
6.6% |
Schizoaffective Disorder |
6.6% |
Insomnia |
4.8% |
Pain |
4.4% |
Schizoaffective Disorder Depressive Type |
3.3% |
Abnormal Behaviour |
2.9% |
Anxiety Disorder |
2.9% |
Mental Disorder |
2.9% |
Fibromyalgia |
2.6% |
Mood Swings |
2.6% |
Neuralgia |
2.6% |
Post-traumatic Stress Disorder |
2.6% |
Sleep Disorder |
2.6% |
Anaesthesia |
1.8% |
Major Depression |
1.5% |
Smoking Cessation Therapy |
1.5% |
|
Drug Interaction |
22.7% |
Gamma-glutamyltransferase Increased |
9.1% |
Hallucination |
7.6% |
Serotonin Syndrome |
7.6% |
Sedation |
6.1% |
Somnolence |
6.1% |
Urinary Retention |
6.1% |
Abnormal Behaviour |
4.5% |
Drug Level Increased |
4.5% |
Tremor |
4.5% |
Hyponatraemia |
3.0% |
Restlessness |
3.0% |
Suicidal Ideation |
3.0% |
Urinary Tract Infection |
3.0% |
Dementia With Lewy Bodies |
1.5% |
Depressed Level Of Consciousness |
1.5% |
Drug Interaction Potentiation |
1.5% |
Drug Withdrawal Syndrome Neonatal |
1.5% |
Hypokinesia |
1.5% |
Oedema Peripheral |
1.5% |
|